Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 3
1972 3
1973 2
1975 1
1976 1
1977 2
1978 1
1979 2
1980 1
1981 4
1982 4
1983 3
1984 4
1985 2
1986 2
1987 1
1988 2
1989 4
1990 2
1991 5
1992 6
1993 3
1994 2
1995 2
1996 3
1998 4
1999 2
2000 3
2001 4
2002 1
2003 4
2004 5
2005 1
2006 4
2007 2
2010 3
2012 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD002063. doi: 10.1002/14651858.CD002063.pub6. Cochrane Database Syst Rev. 2014. PMID: 25238327 Free PMC article. Review.
Corticosteroids for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2010 Feb 17;(2):CD001446. doi: 10.1002/14651858.CD001446.pub3. Cochrane Database Syst Rev. 2010. PMID: 20166061 Updated. Review.
Corticosteroids for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Koningsveld R, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001446. doi: 10.1002/14651858.CD001446.pub2. Cochrane Database Syst Rev. 2006. PMID: 16625544 Updated. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD002063. doi: 10.1002/14651858.CD002063.pub4. Cochrane Database Syst Rev. 2010. PMID: 20556755 Updated. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002063. doi: 10.1002/14651858.CD002063.pub5. Cochrane Database Syst Rev. 2012. PMID: 22786476 Updated. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Raphaël JC, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002063. doi: 10.1002/14651858.CD002063.pub3. Cochrane Database Syst Rev. 2006. PMID: 16437439 Updated. Review.
Immunotherapy for Guillain-Barré syndrome: a systematic review.
Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Hughes RA, et al. Among authors: swan av. Brain. 2007 Sep;130(Pt 9):2245-57. doi: 10.1093/brain/awm004. Epub 2007 Mar 2. Brain. 2007. PMID: 17337484 Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Raphaël JC, Swan AV, van Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2001;(2):CD002063. doi: 10.1002/14651858.CD002063. Cochrane Database Syst Rev. 2001. PMID: 11406030 Updated. Review.
Intravenous immunoglobulin for Guillain-Barré syndrome.
Hughes RA, Raphaël JC, Swan AV, Doorn PA. Hughes RA, et al. Among authors: swan av. Cochrane Database Syst Rev. 2004;(1):CD002063. doi: 10.1002/14651858.CD002063.pub2. Cochrane Database Syst Rev. 2004. PMID: 14973982 Updated. Review.
101 results